Market Place
Sourcing Support
InspireMD To Announce First Quarter 2026 Financial Results
27 Apr 2026 //
GLOBENEWSWIRE
InspireMD Releases 2025 Full-Year Financial Results
18 Mar 2026 //
GLOBENEWSWIRE
Inspiremd To Unveil 2025 Q4 And Full-Year Financial Result
09 Mar 2026 //
GLOBENEWSWIRE
Inspiremd Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
20 Jan 2026 //
GLOBENEWSWIRE
InspireMD Announces Pivotal C-GUARDIANS Publication in JACC
12 Jan 2026 //
GLOBENEWSWIRE
CREST-2 Study In NEJM Shows Carotid Artery Stenting Benefits
24 Nov 2025 //
GLOBENEWSWIRE
Inspiremd Issues Inducement Grants Per Nasdaq Lr 5635(C)(4)
21 Nov 2025 //
GLOBENEWSWIRE
Inspiremd Joins Piper Sandler Healthcare Conference
19 Nov 2025 //
GLOBENEWSWIRE
Inspiremd To Announce Third Quarter 2025 Financial Results
21 Oct 2025 //
GLOBENEWSWIRE
InspireMD Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
08 Oct 2025 //
GLOBENEWSWIRE
InspireMD Issues Inducement Grants Per Nasdaq LR 5635(c)(4)
25 Sep 2025 //
GLOBENEWSWIRE
InspireMD to Present at Wainwright Global Investment Conference
27 Aug 2025 //
GLOBENEWSWIRE
InspireMD Reports Second Quarter 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
InspireMD Announces $58 Million in Combined Financings
31 Jul 2025 //
GLOBENEWSWIRE
InspireMD Appoints Raymond W. Cohen to Board of Directors
31 Jul 2025 //
GLOBENEWSWIRE
InspireMD to Announce Second Quarter 2025 Financial Results
22 Jul 2025 //
GLOBENEWSWIRE
InspireMD Launches CGuard® Carotid Stent for Stroke Prevention
09 Jul 2025 //
GLOBENEWSWIRE
InspireMD Wins FDA Nod for CGuard Prime Carotid Stent
24 Jun 2025 //
GLOBENEWSWIRE
InspireMD gets CE Mark for CGuard® Prime EPS under European MDR
13 Jun 2025 //
GLOBENEWSWIRE
InspireMD Reports First Quarter 2025 Financial Results
09 May 2025 //
GLOBENEWSWIRE
InspireMD to Present at Bank of America 2025 Healthcare Conf.
30 Apr 2025 //
GLOBENEWSWIRE
InspireMD to Announce First Quarter Financial Results
25 Apr 2025 //
GLOBENEWSWIRE
InspireMD Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
08 Apr 2025 //
GLOBENEWSWIRE
InspireMD to Present at 24th Annual Needham Healthcare Conference
26 Mar 2025 //
GLOBENEWSWIRE
InspireMD Reports Q4, Full-Year 2024 Financial Results
12 Mar 2025 //
GLOBENEWSWIRE
InspireMD to Announce Q4 and Full Year 2024 Financial Results
26 Feb 2025 //
GLOBENEWSWIRE
InspireMD Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
25 Feb 2025 //
GLOBENEWSWIRE
InspireMD & NAMSA Partner On CGUARDIANS II Trial For CGuard Prime
13 Feb 2025 //
GLOBENEWSWIRE
InspireMD Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
04 Feb 2025 //
GLOBENEWSWIRE
InspireMD Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
21 Jan 2025 //
GLOBENEWSWIRE
InspireMD Announces CFO Craig Shore’s Expected Retirement in 2025
12 Dec 2024 //
GLOBENEWSWIRE
InspireMD Enrolls 1st Patient in Ph 2 Study for CGuard Prime Stent
09 Dec 2024 //
GLOBENEWSWIRE
InspireMD Appoints Scott R. Ward to Board of Directors
25 Nov 2024 //
GLOBENEWSWIRE
InspireMD Reports Q3 2024 Financial Results and Business Update
12 Nov 2024 //
GLOBENEWSWIRE
InspireMD Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
08 Nov 2024 //
GLOBENEWSWIRE
InspireMD to Report Q3 2024 Results on Nov 12
04 Nov 2024 //
GLOBENEWSWIRE
InspireMD Establishes Global HQ In Miami For CGuard Prime Launch
15 Oct 2024 //
GLOBENEWSWIRE
InspireMD Receives IDE Approval For CGUARDIANS II Pivotal Study
07 Oct 2024 //
GLOBENEWSWIRE
InspireMD Submits PMA For CGuard Prime Stent System
16 Sep 2024 //
GLOBENEWSWIRE
InspireMD Reports Q2 2024 Results And Business Update
06 Aug 2024 //
GLOBENEWSWIRE
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
05 Aug 2024 //
GLOBENEWSWIRE
InspireMD To Report Q2 2024 Results On August 6
30 Jul 2024 //
GLOBENEWSWIRE
InspireMD Announces $17.9M From Full Exercise Of Series H Warrants
01 Jul 2024 //
GLOBENEWSWIRE
InspireMD: Positive 1-Year CGuard Data From IDE Trial At LINC 2024
28 May 2024 //
GLOBENEWSWIRE
InspireMD Reports Q1 2024 Results, Business Update
14 May 2024 //
GLOBENEWSWIRE
InspireMD Q1 2024 Results And Business Update On May 14
07 May 2024 //
GLOBENEWSWIRE
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
03 Apr 2024 //
GLOBENEWSWIRE
InspireMD Abstract Results from the U.S. (IDE) Trial Accepted for Presentation
26 Mar 2024 //
GLOBENEWSWIRE
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results
28 Feb 2024 //
GLOBENEWSWIRE
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial
12 Feb 2024 //
GLOBENEWSWIRE
InspireMD Receives CE Mark Recertification Under EU™s MDR Regulatory Framework
31 Jan 2024 //
GLOBENEWSWIRE
InspireMD Announces Appointment of Pete Ligotti as Executive Vice President
03 Jan 2024 //
GLOBENEWSWIRE
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard System
20 Dec 2023 //
GLOBENEWSWIRE
InspireMD Announces Strategic Agreement with Jacobs Institute
27 Nov 2023 //
GLOBENEWSWIRE
InspireMD Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
InspireMD to Participate in Upcoming November Investor Conferences
02 Nov 2023 //
GLOBENEWSWIRE
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS
01 Nov 2023 //
GLOBENEWSWIRE
InspireMD to Report Third Quarter 2023 Financial Results
30 Oct 2023 //
GLOBENEWSWIRE
InspireMD Supports CMS™ Final NCD Expanding CAS to Include Both Asymptomatic
12 Oct 2023 //
GLOBENEWSWIRE
